SCHEMBL17767985

SCHEMBL17767985

CCCOc1nccc(N)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 3/20 0.46
SCN9A Q15858 1/20 0.45
ALOX5AP P20292 5/20 0.43
FEN1 P39748 5/20 0.43
MAPK8 P45983 1/20 0.43
HSD17B10 Q99714 2/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
TP53 P04637 2/20 0.41
GAA P10253 2/20 0.41
CYP1A2 P05177 1/20 0.41
TLR8 Q9NR97 2/20 0.39
ACACB O00763 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RXRA P19793 1/20 0.38
GRIN1 Q05586 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16631778 0.91 MCHR1 (0.47) MCHR1SCN9AALOX5APFEN1MAPK8
SCHEMBL11076895 0.84 SCN9A (0.47) SCN9AALOX5APFEN1MAPK8LMNA
SCHEMBL14880376 0.83 SCN9A (0.44) SCN9AALOX5APFEN1RXRAGRIN1
SCHEMBL30278077 0.81 SCN9A (0.42) MCHR1SCN9AALOX5APFEN1HSD17B10
SCHEMBL16265343 0.81 SCN9A (0.45) SCN9AALOX5APFEN1RXRAGRIN1
SCHEMBL12487754 0.80 NOS1 (0.45) SCN9ANOS3NOS1NOS2
SCHEMBL17767964 0.79 NUDT1 (0.44) SCN9AALOX5APFEN1MAPK8RXRA
SCHEMBL14374 0.79 SCN9A (0.44) SCN9AALOX5APFEN1RXRAGRIN1
SCHEMBL20012069 0.79 SCN9A (0.44) SCN9AALOX5APFEN1GAAALDH1A1
SCHEMBL14345363 0.78 MAPK8 (0.43) MAPK8HSD17B10HTTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4396191-A1 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2024-07-10 EP disclosed
WO-2023033740-A1 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2023-03-09 WO disclosed
EP-3221316-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS Glaxosmithkline Intellectual Property (No. 2) Limited (GB) 2017-09-27 EP disclosed
WO-2016079709-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2016-05-26 WO disclosed
CN-104080782-A Novel imidazole amines as modulators of kinase activity MERCK PATENT GMBH 2014-10-01 CN disclosed